Beyond its role in development, IGFBP5 has been investigated in pathologies such as idiopathic pulmonary fibrosis (IPF) (49), liver disease (50), obesity (51), and the negative impacts of aging (52). Here, IGFBP5 is linked to idiopathic pulmonary fibrosis.